ITRM (STOCKS)
Iterum Therapeutics plc Ordinary Share
$0.310000
+0.014000 (+4.73%)
Prev close: $0.296000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Corey N. Fishman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $15.51M
- Employees
- 9
- P/E (TTM)
- -0.39
- P/B (TTM)
- -1.94
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.20 | $-0.11 | -0.0878 | -78.25% |
|
Jun 2025 (Q2)
|
$-0.16 | $-0.11 | -0.0478 | -42.60% |
|
Mar 2025 (Q1)
|
$-0.14 | $-0.15 | +0.0079 | +5.34% |
|
Dec 2024 (Q4)
|
$-0.23 | $-0.22 | -0.0107 | -4.88% |
Financial Statements
| Revenues | $390.00K |
| Nonoperating Income/Loss | -$6.05M |
| Operating Expenses | $21.03M |
| Research and Development | $4.15M |
| Other Operating Expenses | $3.43M |
| Operating Income/Loss | -$20.64M |
| Income/Loss From Continuing Operations After Tax | -$26.96M |
| Income/Loss From Continuing Operations Before Tax | -$26.69M |
| Income Tax Expense/Benefit | $276.00K |
| Net Income/Loss | -$26.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$26.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$26.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.72 |
| Diluted Earnings Per Share | -$0.72 |
| Basic Average Shares | 85,161,922 |
| Diluted Average Shares | 85,161,922 |
| Assets | $32.50M |
| Current Assets | $13.73M |
| Inventory | $1.15M |
| Other Current Assets | $12.58M |
| Noncurrent Assets | $18.78M |
| Fixed Assets | $18.00K |
| Intangible Assets | $18.71M |
| Other Non-current Assets | $48.00K |
| Liabilities | $39.88M |
| Current Liabilities | $6.43M |
| Accounts Payable | $577.00K |
| Wages | $882.00K |
| Other Current Liabilities | $4.97M |
| Noncurrent Liabilities | $33.45M |
| Long-term Debt | $20.05M |
| Other Non-current Liabilities | $13.41M |
| Equity | -$7.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$7.38M |
| Liabilities And Equity | $32.50M |
| Net Cash Flow From Operating Activities | -$19.51M |
| Net Cash Flow From Operating Activities, Continuing | -$19.51M |
| Net Cash Flow From Investing Activities | $1.09M |
| Net Cash Flow From Investing Activities, Continuing | $1.09M |
| Net Cash Flow From Financing Activities | $16.04M |
| Net Cash Flow From Financing Activities, Continuing | $16.04M |
| Exchange Gains/Losses | -$22.00K |
| Net Cash Flow | -$2.41M |
| Net Cash Flow, Continuing | -$2.39M |
| Comprehensive Income/Loss | -$26.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$26.96M |
| Other Comprehensive Income/Loss | -$15.49M |